Roivant Sciences Ltd. (ROIV)
41.85
+0.66
(+1.60%)
USD |
NASDAQ |
Nov 11, 16:00
41.03
-0.82
(-1.96%)
After-Hours: 20:00
Roivant Sciences Total Assets (Quarterly) : 4.976B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.976B |
| June 30, 2026 | 5.306B |
| March 31, 2026 | 5.728B |
| December 31, 2025 | 5.225B |
| September 30, 2025 | 5.063B |
| June 30, 2025 | 5.033B |
| March 31, 2025 | 5.437B |
| December 31, 2024 | 5.792B |
| September 30, 2024 | 6.206B |
| June 30, 2024 | 6.496B |
| March 31, 2024 | 7.222B |
| December 31, 2023 | 7.313B |
| September 30, 2023 | 2.066B |
| June 30, 2023 | 2.137B |
| Date | Value |
|---|---|
| March 31, 2023 | 2.390B |
| December 31, 2022 | 2.203B |
| September 30, 2022 | 2.216B |
| June 30, 2022 | 2.600B |
| March 31, 2022 | 2.585B |
| December 31, 2021 | 2.799B |
| September 30, 2021 | 3.103B |
| June 30, 2021 | 2.555B |
| March 31, 2021 | 2.690B |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | 2.477B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Bicycle Therapeutics Plc | 567.18M |
| Immunovant, Inc. | 760.97M |
| Adaptimmune Therapeutics Plc | -- |
| Kiniksa Pharmaceuticals International Plc | 983.24M |
| Autolus Therapeutics Plc | 523.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 380.10M |
| Shareholders Equity (Quarterly) | 4.020B |
| Debt to Equity Ratio | 0.0265 |
| Current Ratio | 15.56 |
| Net Debt Paydown Yield | -0.01% |